<DOC>
	<DOCNO>NCT02999945</DOCNO>
	<brief_summary>In prospective randomize controlled multi center trial investigator stratify `` Very Low Birthweight `` ( VLBW ) -infants growth retardation small gestational age ( SGA ) intrauterine growth restrict ( IUGR ) - infant aim investigate impact nutritional management enhance nutrient discharge 52nd week postconceptional age growth , body composition , metabolic programming , metabolomics , microbiome long term neurodevelopmental outcome . In study , investigator evaluate difference metabolic profile SGA IUGR preterm infant . The investigator longitudinally assess , different nutritional intervention affect alter pathway first year life identify , combination data available metabolic marker , microbiome breast milk analysis , potential pathway result increased disease risk later life .</brief_summary>
	<brief_title>Optimal Growth Preterm Infants With Growth Restriction</brief_title>
	<detailed_description>Prematurity lead cause mortality morbidity newborns low birth weight ( VLBW ) infant ( &lt; 1500g birth weight ) high risk . Ten thirty percent VLBW infant also bear small gestational age define birth weight 10th percentile . In daily neonatal intensive care , consequential long term-follow study growth restrict premature infant treat , importantly include nutritional management birth . However , different group patient different causal pathology subsume definition growth restriction bear small . One group growth restrict patient refers infant bear constitutionally small small gestational age ( SGA ) . The group refer infant intrauterine growth restriction ( IUGR ) cause complex antenatal pathology . Consequently , nutritional management birth important minimize potential risk develop obesity , diabetes cardiovascular disease later life achieve optimal growth . So far consider different underlie pathomechanisms growth restriction nutritional concept preterm infant therefore cause long-term consequence . The European society pediatric gastroenterology , hematology nutrition ( ESPGHAN ) recommend feed enhance nutrient 52nd week gestation growth restrict preterm infants- regardless SGA IUGR premature . Actually , reliable data guaranteeing recommend `` enhanced nutrient strategy '' provide extra nutrient 52 week SGA IUGR infant safe effective group term long-term growth metabolic programming lacking . A total 348 preterm infant bear discharge 10th percentile term include study stratify accord SGA IUGR combination antenatal ultrasound parameter growth parameter ( include 10 % screening failures 20 % drop . Furthermore IUGR SGA growth restrict preterm infant stratify accord breastfeed formula feed randomize one follow group : Standard nutrient group ( breastfeed starter formula ) Enhanced nutrient group ( fortify breast milk post-discharge formula . Body composition measurement perform air displacement plethysmography - non-invasive method . Anthropometric measurement perform measure weight , height head circumference . Furthermore , parameter metabolic programming , metabolomics , stool microbiome neurodevelopmental outcome determine . Additionally , stool microbiome characterize infant stool sample compare two group . After interventional period three month infant follow 2 year age .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Failure Thrive</mesh_term>
	<mesh_term>Neurologic Manifestations</mesh_term>
	<criteria>Preterm infant birth weight &lt; 1500g birth weight &lt; 10th percentile . Weight term &lt; 10th percentile Informed consent Genetic metabolic diseases primary effect growth Necrotizing enterocolitis Intraventricular hemorrhage ( IVH ) &gt; Grade II Periventricular leukomalacia ( PVL ) Stage III Genetic metabolic disorder Bronchopulmonary dysplasia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>42 Weeks</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>preterm infant</keyword>
	<keyword>SGA infant</keyword>
	<keyword>IUGR infant</keyword>
	<keyword>growth</keyword>
	<keyword>body composition</keyword>
	<keyword>metabolomics</keyword>
	<keyword>microbiome</keyword>
	<keyword>adiposity marker</keyword>
	<keyword>metabolic programming</keyword>
	<keyword>neurodevelopmental outcome</keyword>
</DOC>